(Q46859633)

English

Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism

scientific article published on 19 November 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

Asenapine improves phencyclidine-induced object recognition deficits in the rat: evidence for engagement of a dopamine D1 receptor mechanism (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

author name string

Shikha Snigdha

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

Nagi Idris

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

Ben Grayson

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

Mohammed Shahid

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

publication date

19 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

214

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

843-853

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Magnitude of the object recognition deficit associated with perirhinal cortex damage in rats: Effects of varying the lesion extent and the duration of the sample period

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Memory for spatial location and object-place associations are differently processed by the hippocampal formation, parahippocampal areas TH/TF and perirhinal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Subchronic effects of phencyclidine on dopamine and serotonin receptors: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Glutamate and schizophrenia: beyond the dopamine hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Electrophysiological characterization of the effects of asenapine at 5-HT(1A), 5-HT(2A), alpha(2)-adrenergic and D(2) receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Sertindole improves sub-chronic PCP-induced reversal learning and episodic memory deficits in rodents: involvement of 5-HT(6) and 5-HT (2A) receptor mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Altered frontal cortical dopaminergic transmission in monkeys after subchronic phencyclidine exposure: involvement in frontostriatal cognitive deficits

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Asenapine effects in animal models of psychosis and cognitive function

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

The role of cognition in vocational functioning in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

A preliminary investigation into the effects of antipsychotics on sub-chronic phencyclidine-induced deficits in attentional set-shifting in female rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Role of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Postnatal phencyclidine‐induced deficit in adult water maze performance is associated with N‐methyl‐d‐aspartate receptor upregulation

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Influence of gender on working and spatial memory in the novel object recognition task in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Asenapine maleate: a new drug for the treatment of schizophrenia and bipolar mania

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2091-5

21 January 2018

Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks

1 reference

https://pubmed.ncbi.nlm.nih.gov/21088957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of asenapine in acute schizophrenia: a placebo- and risperidone-controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21088957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Asenapine approved for treatment of schizophrenia, bipolar disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/21088957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/21088957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21088957

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-010-2091-5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/21088957

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46859633&oldid=2208184971"